Sedative Premedication in Coronary Angiography
- Conditions
- Sedative PremedicationCoronary Angiography
- Interventions
- Drug: Placebo Oral Tablet
- Registration Number
- NCT03576456
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Brief Summary
Evaluation of the possible positive effect of sedative premedication prior to coronary angiography in regards to pain and anxiety.
- Detailed Description
Coronary angiography is an invasive procedure that can cause patient discomfort. Sedative premedication before coronary angiography could be used to reduce anxiety and pain, but evidence is lacking. Previous trials were predominantly conducted in men and in coronary interventions with femoral access. Recently, radial access has become the preferred route for performing coronary angiograms (RIVAL trial) In this setting, sedative premedication could be of interest to reduce radial spasms, patient anxiety and pain.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 264
- elective coronary angiography
- planned PCI
- use of sedative medication at home
- use of alcohol
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Alprazolam Alprazolam 0.5 mg Patients receive alprazolam 0.5 mg 1 hour prior to coronary angiography. Placebo Oral Tablet Placebo Oral Tablet Patients receive placebo 1 hour prior to coronary angiography.
- Primary Outcome Measures
Name Time Method periprocedural pain: visual analogue scale Assessed after the coronary angiography, within 4 hours. pain during to coronary angiography. Assessed after the procedure through a visual analogue scale for pain. The VAS scale is a visual scale ranging from 0 (no pain) to 100 (extreme pain).
preprocedural anxiety: visual analogue scale Assessed before the coronary angiography anxiety prior to coronary angiography. Assessed before the procedure through a visual analogue scale for anxiety (VAS-A). The VAS is a visual scale ranging from 0 to 100 with 0 begin no anxiety at all and 100 begin extreme anxiety.
- Secondary Outcome Measures
Name Time Method radial spasm during procedure spasm of the radial artery as experienced by operator. There is no precise measurement up until today.
vascular site access complication during procedure need to switch to femoral access, assessed by the operator.
Trial Locations
- Locations (1)
Adriaan Wilgenhof
🇧🇪Brussels, Jette, Belgium